TY - JOUR
T1 - Informe 2017 de la Iniciativa Global para el Diagnóstico, Tratamiento y Prevención de la Enfermedad Pulmonar Obstructiva Crónica
T2 - Resumen Ejecutivo de GOLD
AU - Vogelmeier, Claus F.
AU - Criner, Gerard J.
AU - Martínez, Fernando J.
AU - Anzueto, Antonio
AU - Barnes, Peter J.
AU - Bourbeau, Jean
AU - Celli, Bartolome R.
AU - Chen, Rongchang
AU - Decramer, Marc
AU - Fabbri, Leonardo M.
AU - Frith, Peter
AU - Halpin, David M.G.
AU - López Varela, M. Victorina
AU - Nishimura, Masaharu
AU - Roche, Nicolás
AU - Rodríguez-Roisin, Roberto
AU - Sin, Don D.
AU - Singh, Dave
AU - Stockley, Robert
AU - Vestbo, Jørgen
AU - Wedzicha, Jadwiga A.
AU - Agustí, Alvar
N1 - Publisher Copyright:
© 2017 SEPAR
PY - 2017/3/1
Y1 - 2017/3/1
N2 - This Executive Summary of the Global Strategy for the Diagnosis, Management, and Prevention of COPD (GOLD) 2017 Report focuses primarily on the revised and novel parts of the document. The most significant changes include: 1) the assessment of COPD has been refined to separate the spirometric assessment from symptom evaluation. ABCD groups are now proposed to be derived exclusively from patient symptoms and their history of exacerbations; 2) for each of the groups A to D, escalation strategies for pharmacological treatments are proposed; 3) the concept of de-escalation of therapy is introduced in the treatment assessment scheme; 4) nonpharmacologic therapies are comprehensively presented and; 5) the importance of comorbid conditions in managing COPD is reviewed.
AB - This Executive Summary of the Global Strategy for the Diagnosis, Management, and Prevention of COPD (GOLD) 2017 Report focuses primarily on the revised and novel parts of the document. The most significant changes include: 1) the assessment of COPD has been refined to separate the spirometric assessment from symptom evaluation. ABCD groups are now proposed to be derived exclusively from patient symptoms and their history of exacerbations; 2) for each of the groups A to D, escalation strategies for pharmacological treatments are proposed; 3) the concept of de-escalation of therapy is introduced in the treatment assessment scheme; 4) nonpharmacologic therapies are comprehensively presented and; 5) the importance of comorbid conditions in managing COPD is reviewed.
KW - COPD
KW - COPD management
KW - COPD prevention
KW - Chronic obstructive pulmonary disease
KW - diagnosis
UR - http://www.scopus.com/inward/record.url?scp=85014375458&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85014375458&partnerID=8YFLogxK
U2 - 10.1016/j.arbr.2017.02.001
DO - 10.1016/j.arbr.2017.02.001
M3 - Article
C2 - 28274597
AN - SCOPUS:85014375458
VL - 53
SP - 128
EP - 149
JO - Archivos de Bronconeumologia
JF - Archivos de Bronconeumologia
SN - 0300-2896
IS - 3
ER -